Cyclic compound having dopamine D3 receptor antagonistic effect

A compound represented by Formula (I):

• wherein a group represented by:
• is
• wherein the dashed line represents the presence or absence of a bond;
• R1a and R1b are each independently substituted or unsubstituted 5- to 6-membered aromatic heterocyclyl;
• R1c is substituted or unsubstituted 5-membered aromatic heterocyclyl;
• R9 is each independently halogen, hydroxy, cyano, substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy;
• two R9 s attached to different ring-constituting atoms may be taken together to form a substituted or unsubstituted (C1-C3) bridge wherein one of carbon atoms constituting the (C1-C3) bridge may be replaced with an oxygen atom or a nitrogen atom;
• s is an integer of 0 to 4;
• R2a is each independently a hydrogen atom, halogen, hydroxy, cyano, substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy;
• R2b is each independently a hydrogen atom, halogen, hydroxy, cyano, substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy;
• R2c and R2d are each independently a hydrogen atom, halogen, hydroxy, cyano, substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy;
• -L- is —N(R10)—C(═O)— or —N(R10)—SO2—;
• a bonding hand “a” is bonded to —CR2cR2d—;
• a bonding hand “b” is bonded to —N(R10)—;
• R10 is a hydrogen atom, or substituted or unsubstituted alkyl;
• Ring B is a 6-membered non-aromatic carbocycle or a 6-membered non-aromatic heterocycle;
• r is an integer of 0 to 4;
• R3 is each independently halogen, hydroxy, cyano, substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy;
• two R3 s attached to different ring-constituting atoms may be taken together to form a bond or a substituted or unsubstituted (C1-C3) bridge wherein one of carbon atoms constituting the (C1-C3) bridge may be replaced with an oxygen atom or a nitrogen atom;
• R4 is substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted aromatic heterocyclyl, —CR5aR5b—R6, or —CR7a ═CR7b—R8;
• R5a, R5b, R7a and R7b are each independently a hydrogen atom, halogen, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C1-C6 alkyloxy,
• R6 is substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted aromatic heterocyclyl, substituted or unsubstituted aromatic carbocyclyloxy, substituted or unsubstituted non-aromatic carbocyclyloxy, substituted or unsubstituted aromatic heterocyclyloxy, or substituted or unsubstituted non-aromatic heterocyclyloxy;
• and
• R8 is substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, or substituted or unsubstituted aromatic heterocyclyl,
• or a pharmaceutically acceptable salt thereof.